ArticleHeliyon2024
Landscape of infiltrated immune cell characterization in COVID-19.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- A Unique Patient Stratification Method Combined with a Machine Learning Approach Identifies Novel Genetic Susceptibility and Protective Factors for Severe COVID-19 in a Hungarian Population.International journal of molecular sciences · 2026Article
- Glioblastoma-A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Although the role of SARS-CoV-2-specfic immune cells has been revealed, a comprehensive understanding of immune patterns remains unknown. Methods: In this work, unsupervised consensus clustering analysis was used to classify 240 coronavirus disease 2019 (COVID-19) patients into different immune subtypes. Next, we performed differentially expressed analysis between different immune subtypes. Functional enrichment and pathway analyses were employed to reveal the biological significance of these differentially expressed genes (DEGs). Besides, we compared feature score of some DEGs between whole blood and lung tissues. Then, we utilized the "GSVA" algorithm to construct an immune cell infiltrating (ICI) tool based on the categories of these DEGs. Finally, we developed a nomogram associated with severity of COVID-19. Results: As a result, we identified two immune subtypes, and 238 DEGs which mainly participated in some immune-related functions and the COVID-19 pathway. Most importantly, the 238 DEGs could reflect the characterization of immune patterns in lung tissues. ICI scores were markedly negative associated with immune scores. It was worth noting that ICI score was a strong indicator for severity of COVID-19 and could accurately predict the severity of COVID-19. Conclusion: Our findings could provide more valuable strategies for the management of COVID-19.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.